Synerkine Pharma
Synerkine Pharma is a developer of fusion proteins for the treatment of chronic pain.
Synerkine Pharma has raised €12M across 3 funding rounds from 5 investors, most recently a Series A round in Oct 2023. Based in Utrecht, Netherlands; founded 2018; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€12M
€12,100,000
Funding rounds
3
Investors
5
distinct backers
Active since
2019-01
latest 2023-10
Funding by year
EUR raised per yearSynerkine Pharma — funding by year — interactive chart.
Data table
| Synerkine Pharma — funding by year | |
|---|---|
| 2018 | €3.3M |
| 2021 | €3.5M |
| 2023 | €5.3M |
Signals
High confidenceRaise-next likelihood13
base rate 44% for Series A
- ▼ Past typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
- ▲ 8y since founding (typical exit age)
- ▼ No recent equity round (debt-only or quiet)
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-10-13 | Series A | €5.3M | Flerie Invest,InnovationQuarter,Thuja Capital,Utrecht Health Seed Fund | View deal → |
| 2021-12-17 | Series A | €3.5M | Flerie Invest,Thuja Capital,Utrecht Holdings | View deal → |
| 2019-01-01 | Series A | €3.3M | Thuja Capital | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Picnic€1.7BNetherlands · E-commerce
- Just Eat Takeaway€1.6BNetherlands · Foodtech
- Nebius€1.5BNetherlands · Cloud
- CMR Surgical€1.5BUK · Healthtech
Global coverage: FundingData